Screener Companies About
OTC:PNXP
Healthcare Drug Manufacturers - Specialty & Generic

PINEAPPLE EXPRESS CANNABIS Co

A loss-making OTC cannabis retailer and producer seeking capital growth through equity issuances despite negligible current assets and liabilities.

■ Key Metrics

Revenue
$16.2K
Net Income
$-31.2K
Gross Profit
$16.2K
Operating Cash Flow
$-45.0K
Total Assets
$0
Shareholders' Equity
$-2.1K
Cash & Equiv
$0

⚖ Investment Thesis

Bull Case

Investors may view this as a deep-value turnaround play where current liabilities are minimal relative to the potential upside of a successful market re-entry. The lack of debt provides flexibility for management to pivot business strategy once capital markets stabilize or operational efficiency improves.

Bear Case

The stock carries extreme risk due to a massive retained earnings deficit and total assets of zero, suggesting potential insolvency or delisting from OTC markets. Without significant revenue growth over the past five years, there is no fundamental basis for share price appreciation absent a major strategic acquisition.

◉ About PINEAPPLE EXPRESS CANNABIS Co

Pineapple Express Cannabis Co. is a small-cap cannabis operator focused on producing and distributing high-quality flower and derived products within regulated markets. The company currently reports minimal revenue with significant operating losses driven by general and administrative expenses, relying heavily on capital raises to fund operations.

⚙ Analysis

Management Discussion

Recent financial performance shows a net loss of $31M driven by operating expenses exceeding revenue, resulting in a cash flow from operations deficit. Management has utilized over $45M in financing cash flows via common share issuances to cover losses, yet the company remains asset-light with zero current and long-term assets.

Industry Overview

The global cannabis industry is transitioning from early adoption to mature regulation, offering substantial long-term market potential but requiring significant capital expenditure for compliance and cultivation. Small-cap players like PNXP face intense competition from larger vertically integrated producers who have established supply chains and brand loyalty.

☰ Financial Statements

Income Statement
Balance Sheet
Cash Flow
Metric202320242025
Revenue$5.4K$0$16.2K
Cost of Revenue$0$0$0
Gross Profit$5.4K$0$16.2K
Operating Expenses$21.7K$59.5K$33.0K
Operating Income$-16.3K$-59.5K$-16.9K
G&A$21.7K$59.5K$18.8K
Stock-Based Comp$70——
Depreciation$2.8K$460—
Other OpEx$0$0$14.2K
Non-Operating Income$-28.1K$0$-14.3K
Pre-Tax Income$-44.4K$-59.5K$-31.2K
Income Tax$0$0$0
Continuing Ops$-44.4K$-59.5K$-31.2K
Discontinued Ops$0$0$0
Net Income$-44.4K$-59.5K$-31.2K
Minority Interest$0$0$0
Net to Common$-44.4K$-59.5K$-31.2K
Metric202320242025
Current Assets—$30$0
Cash & Equivalents—$30$0
Other Current Assets—$0$0
Long-Term Assets—$1.8K$0
PP&E (Net)$2.3K$1.8K$0
Other LT Assets—$0$0
Total Assets$2.3K$1.9K$0
Current Liabilities$546.6K$17.8K$2.1K
Accounts Payable$1.3K$17.8K—
Other Current Liab$545.3K$0—
Long-Term Liabilities$0$0$0
Total Liabilities$546.6K$17.8K$2.1K
Shareholders' Equity$-544.4K$-15.9K$-2.1K
Paid-In Capital$19.6K$887.9K$651.7K
Retained Earnings$-583.0K$-642.5K$-673.6K
Total L&E$2.3K$1.9K$0
Metric202320242025
Net Income (CFO)$-44.4K$-59.5K$-31.2K
Non-Cash Adjustments$31.0K$43.0K$410
Working Capital Changes$-3.3K$16.5K$-14.3K
Cash from Operations$-16.7K$30$-45.0K
Cash from Investing$0—$0
Cash from Financing$11.5K—$45.0K
FX Effect$0$0$0
Net Change in Cash$-5.3K$30$-30
Beginning Cash—$0$30
Ending Cash—$30$0

Frequently Asked Questions

How does PINEAPPLE EXPRESS CANNABIS Co make money?

The primary revenue stream consists of direct sales of cannabis flower and consumer products. Operations are characterized by a lack of diversified product lines or geographic expansion, resulting in concentrated risk on core retail and wholesale activities which generated $16M in gross profit but were offset by high operating costs.

What are the main risks for PNXP?

The company is in a severe liquidity crisis with zero ending cash and negative shareholders' equity of $2M. Revenue has been negligible over the last five years, indicating an inability to generate organic growth or profitable operations. Heavy reliance on frequent common share issuances dilutes existing shareholder value without corresponding earnings improvement.

What is PNXP's competitive advantage?

Access to emerging state-regulated markets with potentially lower tax burdens compared to legacy states. The company maintains zero long-term debt and no preferred equity obligations, providing a clean balance sheet for future restructuring if capital becomes available.

Related Companies

Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.